Screener
Wave Life Sciences WVE Free cash flow margin
Discontinued — last reported Q1 '23
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
Based on trailing twelve months.
The source filing: Wave Life Sciences’s 10-Q, filed May 3, 2023. Open the filing →
- Filed
- May 3, 2023
- Fiscal quarter
- Q1 FY2023
- Calendar quarter
- Q1 2023
- Accession
- 0000950170-23-016888
FAQ
- What is Wave Life Sciences's free cash flow margin?
- Wave Life Sciences (WVE) reported free cash flow margin of -27.2% in Q1 2023.
- How has Wave Life Sciences's free cash flow margin changed year-over-year?
- Wave Life Sciences's free cash flow margin increased by 86.4% year-over-year, from -199.4% to -27.2%.
- What is the long-term trend for Wave Life Sciences's free cash flow margin?
- Over 2 years (2020 to 2022), Wave Life Sciences's free cash flow margin has grown at a 146.1% compound annual growth rate (CAGR), from -584.4% to -3,539.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Wave Life Sciences's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude